NO20003687L - Krystallinsk TNF-<alfa>-konverterende enzym og anvendelse derav - Google Patents

Krystallinsk TNF-<alfa>-konverterende enzym og anvendelse derav

Info

Publication number
NO20003687L
NO20003687L NO20003687A NO20003687A NO20003687L NO 20003687 L NO20003687 L NO 20003687L NO 20003687 A NO20003687 A NO 20003687A NO 20003687 A NO20003687 A NO 20003687A NO 20003687 L NO20003687 L NO 20003687L
Authority
NO
Norway
Prior art keywords
alfa
tnf
crystalline
converting enzyme
enzyme
Prior art date
Application number
NO20003687A
Other languages
English (en)
Other versions
NO20003687D0 (no
Inventor
Roy A Black
Raymond James Paxton
Wolfram Bode
Klaus Maskos
Carlos Fernandez-Catalan
James Ming Chen
Jeremy Ian Levin
Original Assignee
Immunex Corp
Max Planck Inst For Biochemist
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp, Max Planck Inst For Biochemist, American Home Prod filed Critical Immunex Corp
Publication of NO20003687D0 publication Critical patent/NO20003687D0/no
Publication of NO20003687L publication Critical patent/NO20003687L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO20003687A 1998-02-04 2000-07-18 Krystallinsk TNF-<alfa>-konverterende enzym og anvendelse derav NO20003687L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7370998P 1998-02-04 1998-02-04
US5008398A 1998-03-30 1998-03-30
US11747699P 1999-01-27 1999-01-27
PCT/US1999/002185 WO1999040182A2 (en) 1998-02-04 1999-02-03 CRYSTALLINE TNF-α-CONVERTING ENZYME AND USES THEREOF

Publications (2)

Publication Number Publication Date
NO20003687D0 NO20003687D0 (no) 2000-07-18
NO20003687L true NO20003687L (no) 2000-09-19

Family

ID=27367666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003687A NO20003687L (no) 1998-02-04 2000-07-18 Krystallinsk TNF-<alfa>-konverterende enzym og anvendelse derav

Country Status (15)

Country Link
EP (1) EP1053304B1 (no)
JP (1) JP2004503202A (no)
CN (1) CN1342200A (no)
AR (2) AR015513A1 (no)
AT (1) ATE366303T1 (no)
AU (1) AU2574099A (no)
CA (1) CA2319040A1 (no)
DE (1) DE69936445T2 (no)
DK (1) DK1053304T3 (no)
ES (1) ES2293718T3 (no)
HU (1) HUP0101596A1 (no)
IL (3) IL163513A0 (no)
NO (1) NO20003687L (no)
NZ (1) NZ505959A (no)
WO (1) WO1999040182A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
WO2002033118A2 (en) * 2000-08-03 2002-04-25 The Texas A & M University System Isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
US7138264B1 (en) 2002-05-24 2006-11-21 Schering Corporation Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
WO2005073400A2 (en) * 2004-01-26 2005-08-11 University Of Massachusetts Method of identifying amp- activated protein kinase (ampk) modulators and uses therefor
TWI516274B (zh) * 2013-11-27 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5702935A (en) * 1994-04-28 1997-12-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method and compounds for inhibiting lipid biosynthesis of bacteria and plants
ATE274346T1 (de) * 1995-06-08 2004-09-15 Immunex Corp Tnf-alpha konvertierendes enzym
KR19990063585A (ko) * 1995-08-30 1999-07-26 데이비드 엘. 버스테인 결정상 zap계 단백질
WO1997015588A1 (en) * 1995-10-26 1997-05-01 St. Jude Children's Research Hospital Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design
CA2249985A1 (en) * 1996-03-26 1997-10-02 Glaxo Group Limited Tumour necrosis factor alpha convertase

Also Published As

Publication number Publication date
CA2319040A1 (en) 1999-08-12
IL163513A0 (en) 2005-12-18
HUP0101596A1 (hu) 2001-08-28
DE69936445D1 (de) 2007-08-16
AU2574099A (en) 1999-08-23
AR024804A1 (es) 2002-10-23
JP2004503202A (ja) 2004-02-05
AR015513A1 (es) 2001-05-02
DE69936445T2 (de) 2008-04-10
WO1999040182A3 (en) 1999-10-07
IL137557A0 (en) 2001-07-24
NZ505959A (en) 2003-05-30
ATE366303T1 (de) 2007-07-15
IL163513A (en) 2007-03-08
ES2293718T3 (es) 2008-03-16
EP1053304A2 (en) 2000-11-22
DK1053304T3 (da) 2007-11-05
CN1342200A (zh) 2002-03-27
WO1999040182A2 (en) 1999-08-12
NO20003687D0 (no) 2000-07-18
EP1053304B1 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
NO20032753L (no) Forbindelse og anvendelse derav
NO20004947D0 (no) Presipitert kalsiumkarbonat og fremstilling og anvendelse derav
NO990510L (no) Selvutjevnende betong med hoey ytelse, dens fremstilling og anvendelse
NO20010797L (no) Enzym-batteri
DE69924589D1 (de) Einphasige Silikon- und Wasserzusammensetzung
DE69926758D1 (de) Ultraschall-siegler
NO20006488D0 (no) Sammensetning og anvendelse
NO20010483L (no) Gjenget og koplet forbindelse for økt utmatningsfasthet
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20004856L (no) Gelelektrolytt og gelelektrolyttcelle
EE200000644A (et) Interleukiin-1ß-t muundava ensüümi suktsiinamiidinhibiitorid
NO20013013D0 (no) &lt;alfa&gt;v&lt;beta&gt;6-integrininhibitorer
DK1068238T3 (da) Integrinheterodimer og subunit deraf
NO20003687D0 (no) Krystallinsk TNF-&lt;alfa&gt;-konverterende enzym og anvendelse derav
DK0972205T3 (da) Impedans-til-spændingskonverter og fremgangsmåde til konvertering
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20004284D0 (no) Antikorrosjonspigment og anvendelse derav
NO20021305D0 (no) DNA-konstruksjon og dens anvendelse
PT1010689E (pt) Ciclo-heptenos substituidos sua sintese e utilizacao
DE69219440D1 (de) Endothelin-konvertierende Enzyme
NO20002937D0 (no) Fibrinogen-konverterende enzymhybrider
NO20010280L (no) &lt;Alfa&gt;-aminosyrefenylesterderivater
DE69926252D1 (de) Seriell-parallel- und parallel-seriell-umwandlungsvorrichtung
DK0944645T3 (da) Inhibitorer af interleukin-1beta-konverterende enzym
TW409493U (en) Pipe element with siphonic and capillary effect

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application